{"id":"W4415711778","doi":"10.1016/j.jtocrr.2025.100929","title":"Patient-Reported Symptoms and Quality of Life With Sacituzumab Govitecan Versus Docetaxel in Metastatic NSCLC: The Phase 3, Randomized EVOKE-01 Trial","year":2025,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Zymeworks (Canada)","funders":"Gilead UK and Ireland Corporate Contributions; Gilead Sciences","keywords":"Docetaxel; Quality of life (healthcare); Randomized controlled trial; Phases of clinical research; Chemotherapy; Exploratory analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007667492,0.0001402824,0.001058714,0.0001709615,0.0001331042,0.00003694122,0.0000414841,0.00008249737,0.00002998184],"category_scores_gemma":[0.01331956,0.00006762279,0.0001625067,0.0004702769,0.001225825,0.00006126732,0.00007752921,0.0004435567,3.558787e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006374375,"about_ca_system_score_gemma":0.001523331,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001816711,"about_ca_topic_score_gemma":0.0003402659,"domain_scores_codex":[0.9956535,0.001065726,0.001740394,0.000446908,0.0008252267,0.0002683065],"domain_scores_gemma":[0.9937918,0.0046169,0.0004328411,0.0004773694,0.0004359166,0.0002451611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9295663,0.0024433,0.02927344,0.0002209217,0.002317736,0.0005480723,0.0004456147,0.000001903327,0.00002880362,0.00067087,0.0004177045,0.0340654],"study_design_scores_gemma":[0.9690326,0.003823354,0.02208765,0.0003190549,0.0008998064,0.00003376646,0.0007055301,0.00009313401,0.00004720992,0.001132534,0.001713402,0.000111909],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902214,0.001420279,0.00004185301,0.002273032,0.0002528584,0.003094018,0.000008731105,0.00001431379,0.002673481],"genre_scores_gemma":[0.9983789,0.0003590776,0.000119973,0.0001128872,0.00005116959,0.0003033233,0.00001907922,0.000008870346,0.0006466811],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0394664,"threshold_uncertainty_score":0.9949917,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1552045560590042,"score_gpt":0.5380789188335684,"score_spread":0.3828743627745642,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}